FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W229836> ?p ?o ?g. }

• W229836 endingPage "60" @default.
• W229836 startingPage "1649" @default.
• W229836 abstract "Proliferation of vascular cells has been previously shown to contribute to spontaneous development of coronary collaterals. Recent studies from several laboratories have established that collateral artery growth in both the heart and limb can be enhanced by administration of angiogenic growth factors, or therapeutic angiogenesis. In this study, we sought (1) to define the extent and time course of endothelial cell (EC) and smooth muscle cell (SMC) proliferation accompanying spontaneous collateral development during limb ischemia and (2) to determine the extent to which proliferative activity of ECs and SMCs is augmented during therapeutic angiogenesis with vascular endothelial growth factor (VEGF), a heparin-binding EC-specific mitogen. Ten days after induction of limb ischemia by surgically excising the femoral artery of rabbits, either VEGF (500 to 1000 micrograms) or saline was administered as a bolus into the iliac artery of the ischemic limb. Cellular proliferation was evaluated by bromodeoxyuridine labeling for 24 hours at day 0 (immediately before VEGF administration) and at days 3, 5, and 7 after VEGF, EC proliferation in the midzone collaterals of VEGF-treated animals increased 2.8-fold at day 5 (P < 0.05 versus control), and returned to baseline levels by day 7. SMC proliferation in midzone collaterals also increased 2.7-fold in response to VEGF (P < 0.05). No significant increase in EC or SMC proliferation was observed in either the stem or re-entry collaterals of VEGF-treated animals compared with untreated ischemic control animals. Reduction of hemodynamic deficit in the ischemic limb measured by lower limb blood pressure was documented at day 7 after VEGF (P < 0.01 versus untreated, ischemic control). These data thus (1) establish the contribution of cellular proliferation to collateral vessel development in limb ischemia and (2) support the concept that augmented cellular proliferation contributes to the enhanced formation of collateral vessels after therapeutic angiogenesis with VEGF." @default.
• W229836 created "2016-06-24" @default.
• W229836 creator A5019293009 @default.
• W229836 creator A5019545100 @default.
• W229836 creator A5021569532 @default.
• W229836 creator A5035928746 @default.
• W229836 creator A5037270460 @default.
• W229836 creator A5052536397 @default.
• W229836 creator A5058992043 @default.
• W229836 creator A5084445039 @default.
• W229836 creator A5090591361 @default.
• W229836 date "1995-12-01" @default.
• W229836 modified "2023-10-18" @default.
• W229836 title "Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency." @default.
• W229836 cites W1488724428 @default.
• W229836 cites W1495489079 @default.
• W229836 cites W1525012305 @default.
• W229836 cites W169622606 @default.
• W229836 cites W1917066306 @default.
• W229836 cites W1983763042 @default.
• W229836 cites W1988648945 @default.
• W229836 cites W1999171451 @default.
• W229836 cites W2007181011 @default.
• W229836 cites W2008305464 @default.
• W229836 cites W2041819693 @default.
• W229836 cites W2043863730 @default.
• W229836 cites W2047408781 @default.
• W229836 cites W2049827480 @default.
• W229836 cites W2061312392 @default.
• W229836 cites W2071140757 @default.
• W229836 cites W2076033729 @default.
• W229836 cites W2080356707 @default.
• W229836 cites W2083092621 @default.
• W229836 cites W2094891357 @default.
• W229836 cites W2108145145 @default.
• W229836 cites W2112128801 @default.
• W229836 cites W2113271100 @default.
• W229836 cites W2116008315 @default.
• W229836 cites W2121594719 @default.
• W229836 cites W2131461932 @default.
• W229836 cites W2133762215 @default.
• W229836 cites W2142401146 @default.
• W229836 cites W2162249561 @default.
• W229836 cites W2170919401 @default.
• W229836 cites W2217772588 @default.
• W229836 cites W223352390 @default.
• W229836 cites W2314203153 @default.
• W229836 cites W2412980596 @default.
• W229836 cites W2418371351 @default.
• W229836 cites W2467811759 @default.
• W229836 cites W29925897 @default.
• W229836 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1869932" @default.
• W229836 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7495290" @default.
• W229836 hasPublicationYear "1995" @default.
• W229836 type Work @default.
• W229836 sameAs 229836 @default.
• W229836 citedByCount "34" @default.
• W229836 countsByYear W2298362014 @default.
• W229836 countsByYear W2298362016 @default.
• W229836 countsByYear W2298362018 @default.
• W229836 countsByYear W2298362019 @default.
• W229836 countsByYear W2298362021 @default.
• W229836 crossrefType "journal-article" @default.
• W229836 hasAuthorship W229836A5019293009 @default.
• W229836 hasAuthorship W229836A5019545100 @default.
• W229836 hasAuthorship W229836A5021569532 @default.
• W229836 hasAuthorship W229836A5035928746 @default.
• W229836 hasAuthorship W229836A5037270460 @default.
• W229836 hasAuthorship W229836A5052536397 @default.
• W229836 hasAuthorship W229836A5058992043 @default.
• W229836 hasAuthorship W229836A5084445039 @default.
• W229836 hasAuthorship W229836A5090591361 @default.
• W229836 hasConcept C126322002 @default.
• W229836 hasConcept C134018914 @default.
• W229836 hasConcept C167734588 @default.
• W229836 hasConcept C204232928 @default.
• W229836 hasConcept C2776599846 @default.
• W229836 hasConcept C2776820930 @default.
• W229836 hasConcept C2777025900 @default.
• W229836 hasConcept C2777408375 @default.
• W229836 hasConcept C2778260397 @default.
• W229836 hasConcept C2778271429 @default.
• W229836 hasConcept C2780394083 @default.
• W229836 hasConcept C2781188250 @default.
• W229836 hasConcept C541997718 @default.
• W229836 hasConcept C71924100 @default.
• W229836 hasConceptScore W229836C126322002 @default.
• W229836 hasConceptScore W229836C134018914 @default.
• W229836 hasConceptScore W229836C167734588 @default.
• W229836 hasConceptScore W229836C204232928 @default.
• W229836 hasConceptScore W229836C2776599846 @default.
• W229836 hasConceptScore W229836C2776820930 @default.
• W229836 hasConceptScore W229836C2777025900 @default.
• W229836 hasConceptScore W229836C2777408375 @default.
• W229836 hasConceptScore W229836C2778260397 @default.
• W229836 hasConceptScore W229836C2778271429 @default.
• W229836 hasConceptScore W229836C2780394083 @default.
• W229836 hasConceptScore W229836C2781188250 @default.

• next